Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    22070868 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment
Conditions: Colon Cancer;   Colorectal Cancer;   Rectal Cancer;   Cancer;   Metastatic Cancer;   Metastatic Colorectal Cancer;   Oncology
Interventions: Biological: Panitumumab;   Drug: FOLFIRI
2 Completed
Has Results
PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Panitumumab;   Drug: FOLFOX regimen
3 Completed
Has Results
Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Panitumumab;   Drug: FOLFIRI
4 Completed
Has Results
Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy
Conditions: Metastatic Colorectal Cancer;   Skin Rash;   Skin Toxicities;   Colon Cancer;   Colorectal Cancer
Interventions: Biological: Panitumumab;   Drug: Irinotecan;   Drug: FOLFIRI;   Drug: Pre-emptive Skin Treatment;   Drug: Reactive Skin Treatment

Indicates status has not been verified in more than two years